Page last updated: 2024-10-30

metformin and Dizzyness

metformin has been researched along with Dizzyness in 5 studies

Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.

Research Excerpts

ExcerptRelevanceReference
"Compared with metformin, vildagliptin combined with metformin could significantly reduce FPG, HbA1c and body weight."5.22Efficacy and safety of combination therapy with vildagliptin and metformin vs. metformin monotherapy for Type 2 Diabetes Mellitus therapy: a meta-analysis. ( Cao, L; Ding, Y; Dong, F; Li, Y; Lin, M; Lin, S; Liu, Y; Qu, Y, 2022)
"Alogliptin monotherapy maintained glycaemic control comparable to that of glipizide in elderly patients with T2DM over 1 year of treatment, with substantially lower risk of hypoglycaemia and without weight gain."5.17Alogliptin versus glipizide monotherapy in elderly type 2 diabetes mellitus patients with mild hyperglycaemia: a prospective, double-blind, randomized, 1-year study. ( Fleck, P; Rosenstock, J; Wilson, C, 2013)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's2 (40.00)24.3611
2020's2 (40.00)2.80

Authors

AuthorsStudies
Mehrpour, O1
Saeedi, F1
Hoyte, C1
Hadianfar, A1
Nakhaee, S1
Brent, J1
Ding, Y1
Liu, Y1
Qu, Y1
Lin, M1
Dong, F1
Li, Y1
Cao, L1
Lin, S1
Rosenstock, J1
Wilson, C1
Fleck, P1
Pratley, RE1
Urosevic, D1
Boldrin, M1
Balena, R1

Reviews

1 review available for metformin and Dizzyness

ArticleYear
Efficacy and safety of combination therapy with vildagliptin and metformin vs. metformin monotherapy for Type 2 Diabetes Mellitus therapy: a meta-analysis.
    European review for medical and pharmacological sciences, 2022, Volume: 26, Issue:8

    Topics: Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Diarrhea; Dizziness; Drug Therapy, Combinatio

2022

Trials

2 trials available for metformin and Dizzyness

ArticleYear
Alogliptin versus glipizide monotherapy in elderly type 2 diabetes mellitus patients with mild hyperglycaemia: a prospective, double-blind, randomized, 1-year study.
    Diabetes, obesity & metabolism, 2013, Volume: 15, Issue:10

    Topics: Aged; Aged, 80 and over; Blood Glucose; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitor

2013
Efficacy and tolerability of taspoglutide versus pioglitazone in subjects with type 2 diabetes uncontrolled with sulphonylurea or sulphonylurea-metformin therapy: a randomized, double-blind study (T-emerge 6).
    Diabetes, obesity & metabolism, 2013, Volume: 15, Issue:3

    Topics: Adolescent; Adult; Blood Glucose; Diabetes Mellitus, Type 2; Dizziness; Double-Blind Method; Drug Ad

2013

Other Studies

2 other studies available for metformin and Dizzyness

ArticleYear
Distinguishing characteristics of exposure to biguanide and sulfonylurea anti-diabetic medications in the United States.
    The American journal of emergency medicine, 2022, Volume: 56

    Topics: Abdominal Pain; Acidosis; Adolescent; Adult; Aged; Child; Creatinine; Diabetes Mellitus; Diarrhea; D

2022
Nateglinide for type 2 diabetes.
    The Medical letter on drugs and therapeutics, 2001, Apr-02, Volume: 43, Issue:1101

    Topics: Administration, Oral; Cyclohexanes; Diabetes Mellitus, Type 2; Dizziness; Humans; Metformin; Nategli

2001